Guidelines International Network | Guidelines International Network (GIN)

Tratamiento quirúrgico de la obesidad mórbida (Informe nº: Osteba D-04-01)

MeSH Terms: Obesity; Morbid (C23.888.144.699.500.500); Bariatric Surgery (E02.065.062); Gastric Bypass (E02.065.062.249); Gastroplasty (E02.065.062.750)
English Title Translation: Surgical treatment of the morbid obesity
Publication Scope: management
Countries of Application: Spain
Guideline Publication Status: Published
Languages: Spanish
Authors: OSTEBA (ES)
Publication Year: 2003

MeSH Terms: Musculoskeletal Diseases (C05); Wounds and Injuries (C26); Joint Diseases (C05.550); Knee Injuries (C26.558.554)
Guideline Contact: Jolanda Wittenberg ([email protected])
English Title Translation: Knee trauma (NL: Traumatische knieproblemen)
Publication Scope: assessment; management
Countries of Application: Netherlands
Guideline Publication Status: Published
Languages: Dutch; English
Authors: NHG (NL)
Publication Year: 2020

MeSH Terms: Hematinics (D27.505.954.502.543); Injections; Intravenous (E02.319.267.082.750); Iron (D01.552.544.412); Iron (D01.268.956.287); Iron (D01.268.556.412); Anemia; Iron-Deficiency (C15.378.071.196.300); Anemia; Iron-Deficiency (C18.452.565.100); Coronary Disease (C14.907.585.250); Coronary Disease (C14.280.647.250); Erythrocyte Transfusion (E02.095.135.140.275); Exercise Tolerance (G11.427.680.270); Heart Failure (C14.280.434)
Guideline Contact: Amir Qaseem ([email protected])
Publication Scope: management
Countries of Application: United States
Guideline Publication Status: Published
Languages: English
Authors: ACP (US)
Publication Year: 2013

Links

MeSH Terms

Adult

Bone Density Conservation Agents* / therapeutic use

Diphosphonates / therapeutic use

Humans

Hypercalcemia* / drug therapy

Hypercalcemia* / etiology

Neoplasms* / complications

Paraneoplastic Syndromes

Guideline Contact

Maureen Corrigan ([email protected])

Publication Scope

Evidence-Based Medicine

Countries of Application

International

Guideline Publication Status

Published

Languages

English

Authors

Endocrine Society

Willingness to Collaborate

Yes

Publication Year

2022

MeSH Terms: Vitamin D (D04.808.812.768); Women (M01.975); Osteoporosis (C05.116.198.579); Pharmacologic Actions (D27.505); Therapeutic Uses (D27.505.954); Alendronate (D02.705.429.500.100); Peptide Hormones (D06.472.699); Peptide Hormones (D12.644.548); Teriparatide (D06.472.699.590.850); Teriparatide (D12.644.548.587.850); Calcitonin (D06.472.699.150); Calcitonin (D12.644.400.095); Calcitonin (D12.644.548.150); Calcitonin (D12.776.641.650.095); Estrogen Replacement Therapy (E02.319.452.150); Selective Estrogen Receptor Modulators (D27.505.696.399.450.360.827); Selective Estrogen Receptor Modulators (D06.347.360.827); Raloxifene (D02.455.426.559.389.150.700.900.775); Osteoporosis; Postmenopausal (C05.116.198.579.610); Calcium (D01.268.552.100); Calcium (D01.552.539.288)
Guideline Contact: Amir Qaseem ([email protected])
Date for Review: 2006-06-22
Publication Scope: prevention; treatment
Countries of Application: United States
Guideline Publication Status: Published
Languages: English
Authors: ACP (US)
Publication Year: 2017